LCP
Lamond Capital Partners Portfolio holdings
AUM
$14.3M
1-Year Est. Return
30.74%
This Fund
S&P 500
1 Year Est. Return
-30.74%
AUM
$14.3M
AUM Growth
-$52.6M
(-79%)
Holding
7
Top Buys
No buys this quarter
Top Sells
| 1 | +$18.3M | |
| 2 | +$17.3M | |
| 3 | +$12.2M | |
| 4 |
AbbVie
ABBV
|
+$2.79M |
| 5 |
RXDX
Ignyta, Inc.
RXDX
|
+$626K |
Sector Composition
| 1 | Healthcare | 100% |
| 2 | Technology | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
AbbVie
ABBV
$414B
| $14.3M | 100% |
250,000
-50,000
|
|
||
|
RXDX
2
DELISTED
Ignyta, Inc.
RXDX
| – | – |
-46,721
|
|
||
|
ZLTQ
3
DELISTED
ZELTIQ Aesthetics, Inc.
ZLTQ
| – | – |
-16,119
|
|
||
4
Amgen
AMGN
$204B
| – | – |
-75,000
|
|
||
5
Oracle
ORCL
$438B
| – | – |
-500,000
|
|
||
6
Puma Biotechnology
PBYI
$313M
| – | – |
-220,780
|
|
||
|
IMMU
7
DELISTED
Immunomedics Inc
IMMU
| – | – |
-100,000
|
|